15:00-15:45

Development of nanomachine equipped nanoparticles for cancer therapy

Targeted delivery and controlled release of anticancer drugs remains a goal for cancer therapy. At the NanoMachine Center, we are developing mechanized nanoparticles that are equipped with a variety of nanomachines that include nanovalves and nanoimpellers. I will first describe construction of these nanoparticles based on mesoporous silica nanoparticles. I will then discuss our animal experiments to demonstrate anti-tumor efficacy of drug loaded mesoporous silica nanoparticles. Finally, I will mention briefly about recent developments concerning nanomedicine research at UCLA.

Speaker

Prof. Fuyu Tamanoi, Department of Microbiology, Immunollogy & Molecular Genetics, Jonsson Comprehensive Cancer Center NanoMachine Center/CNSI, UCLA

Chair

Dr. Yutaka Ikeda, Graduate School of Pure and Applied Sciences, University of Tsukuba